Public filings / VRDN on Yahoo Finance (opens in a new tab)
VRDN: insider buying, 13F holders, analyst moves
Viridian Therapeutics Inc - US
A summary of public filings about Viridian Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold VRDN
Combined reported value $167.5M.
Holders among our 100 managers: 3 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deep Track Capital | $66.0M | 0.97% | Added |
| Avoro Capital Advisors | $45.9M | 0.41% | Added |
| Baker Bros. Advisors | $43.8M | 0.22% | Added |
| Perceptive Advisors | $10.7M | 0.17% | Trimmed |
| Tudor Investment | $1.1M | 0.01% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.